Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7647)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2018 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Di Carlo C, Brandi J, Cecconi D. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World J Stem Cells 2018; 10(11): 172-182 [PMID: 30631392 DOI: 10.4252/wjsc.v10.i11.172] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/172.htm |
| Number | Citing Articles |
| 1 |
Eun-Young Kim, Seong-Uk Lee, Yoon Hee Kim. 1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line. Animal Cells and Systems 2022; 26(6): 328 doi: 10.1080/19768354.2022.2152864
|
| 2 |
Abhishek Dutta, Swastika Paul. Exosome‐based cancer stem cell communication: Implication for detecting and eliminating cancer stem cells. MedComm – Future Medicine 2022; 1(2) doi: 10.1002/mef2.23
|
| 3 |
Ntombikayise Xelwa, Geoffrey Patrick Candy, John Devar, Jones Omoshoro-Jones, Martin Smith, Ekene Emmanuel Nweke. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.683788
|
| 4 |
Hem D Shukla, Tijana Dukic, Sanjit Roy, Binny Bhandary, Andrew Gerry, Yannick Poirier, Narottam Lamichhane, Jason Molitoris, France Carrier, Aditi Banerjee, William F. Regine, Jerimy C. Polf. Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1072774
|
| 5 |
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer. 2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
|
| 6 |
António M. Palma, Vignesh Vudatha, Maria Leonor Peixoto, Esha Madan. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 203 doi: 10.1016/bs.acr.2023.02.005
|
| 7 |
Giulia Ambrosini, Elisa Dalla Pozza, Giuseppina Fanelli, Claudia Di Carlo, Andrea Vettori, Giuseppe Cannino, Chiara Cavallini, Cristian Andres Carmona-Carmona, Jessica Brandi, Sara Rinalducci, Maria Teresa Scupoli, Andrea Rasola, Daniela Cecconi, Marta Palmieri, Ilaria Dando. Progressively De-Differentiated Pancreatic Cancer Cells Shift from Glycolysis to Oxidative Metabolism and Gain a Quiescent Stem State. Cells 2020; 9(7): 1572 doi: 10.3390/cells9071572
|
| 8 |
Eric Russ, Krithika Bhuvaneshwar, Guisong Wang, Benjamin Jin, Michele M. Gage, Subha Madhavan, Yuriy Gusev, Geeta Upadhyay. High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma. Oncotarget 2021; 12(3): 145 doi: 10.18632/oncotarget.27880
|
| 9 |
Md. Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El-Rayes, Herbert Chen, Philip A. Philip, Asfar S. Azmi. Deciphering cellular plasticity in pancreatic cancer for effective treatments. Cancer and Metastasis Reviews 2024; 43(1): 393 doi: 10.1007/s10555-023-10164-5
|
| 10 |
Xiaoqing Wang, Honghao Song, Junyu Liang, Yang Jia, Yongfei Zhang. Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis (Review). Molecular Medicine Reports 2022; 26(6) doi: 10.3892/mmr.2022.12871
|
| 11 |
Joseph W. Franses, Julia Philipp, Pavlos Missios, Irun Bhan, Ann Liu, Chittampalli Yashaswini, Eric Tai, Huili Zhu, Matteo Ligorio, Benjamin Nicholson, Elizabeth M. Tassoni, Niyati Desai, Anupriya S. Kulkarni, Annamaria Szabolcs, Theodore S. Hong, Andrew S. Liss, Carlos Fernandez-del Castillo, David P. Ryan, Shyamala Maheswaran, Daniel A. Haber, George Q. Daley, David T. Ting. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-17150-3
|
| 12 |
Xiao-Yan Huang, Wen-Tao Qin, Qi-Sheng Su, Cheng-Cheng Qiu, Ruo-Chuan Liu, Shan-Shan Xie, Yang Hu, Shang-Yong Zhu, Xiaoping Liu. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6669570
|
| 13 |
Alireza Shokouhifar, Javad Firouzi, Masoumeh Nouri, Gholamreza Anani Sarab, Marzieh Ebrahimi. NK cell upraise in the dark world of cancer stem cells. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02400-1
|
| 14 |
Mukulika Bose, Alexa Sanders, Aashna Handa, Aabha Vora, Manuel R. Cardona, Cory Brouwer, Pinku Mukherjee. Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53549-4
|
| 15 |
Marcello Manfredi, Jessica Brandi, Claudia Di Carlo, Virginia Vita Vanella, Elettra Barberis, Emilio Marengo, Mauro Patrone, Daniela Cecconi. Mining cancer biology through bioinformatic analysis of proteomic data. Expert Review of Proteomics 2019; 16(9): 733 doi: 10.1080/14789450.2019.1654862
|
| 16 |
Claudia Di Carlo, Bebiana C. Sousa, Marcello Manfredi, Jessica Brandi, Elisa Dalla Pozza, Emilio Marengo, Marta Palmieri, Ilaria Dando, Michael J. O. Wakelam, Andrea F. Lopez-Clavijo, Daniela Cecconi. Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92752-5
|
| 17 |
Ravi Gor, Ilangovan Ramachandran, Satish Ramalingam. Targeting the Cancer Stem Cells in Endocrine Cancers with Phytochemicals. Current Topics in Medicinal Chemistry 2022; 22(31): 2589 doi: 10.2174/1567205020666221114112814
|
| 18 |
Seung Wan Son, Mun Gyu Song, Ba Da Yun, Jong Kook Park. Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer. Biomedicines 2021; 9(3): 263 doi: 10.3390/biomedicines9030263
|
| 19 |
Mariafausta Fischietti, Frank Eckerdt, Gavin T. Blyth, Ahmet D. Arslan, William M. Mati, Chidera V. Oku, Ricardo E. Perez, Catalina Lee-Chang, Ewa M. Kosciuczuk, Diana Saleiro, Elspeth M. Beauchamp, Maciej S. Lesniak, Daniela Verzella, Leyu Sun, Eleanor N. Fish, Guang-Yu Yang, Wenan Qiang, Leonidas C. Platanias. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene 2021; 40(18): 3273 doi: 10.1038/s41388-021-01761-1
|
| 20 |
Shuang Zhou, Renle Du, Zhenglu Wang, Wenzhi Shen, Ruifang Gao, Shan Jiang, Yan Fang, Yuzhi Shi, Antao Chang, Lei Liu, Chenghu Liu, Na Li, Rong Xiang. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma. Cancer Medicine 2019; 8(5): 2325 doi: 10.1002/cam4.2070
|
| 21 |
Giuseppe Nicolò Fanelli, Antonio Giuseppe Naccarato, Cristian Scatena. Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00569
|
| 22 |
Archana P. Thankamony, Kritika Saxena, Reshma Murali, Mohit Kumar Jolly, Radhika Nair. Cancer Stem Cell Plasticity – A Deadly Deal. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00079
|
| 23 |
Kah Keng Wong. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications. Cellular Oncology 2020; 43(5): 779 doi: 10.1007/s13402-020-00526-4
|
| 24 |
Akimasa Seno, Said M. Afify, Ghmkin Hassan, Masaharu Seno. iPSC Derived Progenitors. 2022; : 265 doi: 10.1016/B978-0-323-85545-7.00002-8
|
| 25 |
Catalina M. Perelló-Reus, Teresa Rubio-Tomás, Eugenia Cisneros-Barroso, Lesly Ibargüen-González, Juan José Segura-Sampedro, Rafael Morales-Soriano, Carles Barceló. Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.995357
|
| 26 |
Hesham A. El-Mahdy, Ahmed A. El-Husseiny, Yasser I. Kandil, Ayman M. Gamal El-Din. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. Life Sciences 2020; 262: 118518 doi: 10.1016/j.lfs.2020.118518
|
| 27 |
Jyothi Priya Mandala, Srinivas Pittala, Gowru Srivani. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 51 doi: 10.1007/978-3-030-48405-7_3
|
| 28 |
Andreea Nedelcu, Teodora Mocan, Cristiana Grapa, Lucian Mocan. Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(15): 8060 doi: 10.3390/ijms22158060
|
| 29 |
Sabina Quader, Shihori Tanabe, Horacio Cabral. Cancer Stem Cell Markers and Related Network Pathways. Advances in Experimental Medicine and Biology 2022; 1393: 141 doi: 10.1007/978-3-031-12974-2_7
|
| 30 |
Andreia S. Fernandes, Catarina Oliveira, Rui L. Reis, Albino Martins, Tiago H. Silva. Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies. Marine Drugs 2022; 20(11): 689 doi: 10.3390/md20110689
|
| 31 |
Ashleigh R. Poh, Matthias Ernst. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges. Cancers 2021; 13(12): 2860 doi: 10.3390/cancers13122860
|
| 32 |
Benedetta Ferrara, Erica Dugnani, Valeria Sordi, Valentina Pasquale, Silvia Pellegrini, Michele Reni, Gianpaolo Balzano, Lorenzo Piemonti. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(18): 10663 doi: 10.3390/ijms231810663
|